Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 48 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 10292979

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted

  2. US 2019144465

    Macrocyclic MCL-1 inhibitors and methods of use

    ABBVIE INC [US] · Granted May 16, 2019 · Expires May 11, 2039

    granted

  3. US 10287295

    TGF-β inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 14, 2019 · Expires May 9, 2039

    granted

  4. US 10287279

    Inhibitors of human 12/15-lipoxygenase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  5. US 10280171

    Heterocyclic inhibitors of PTPN11

    The Board of Regents of the University of Texas System · Granted May 7, 2019 · Expires May 2, 2039

    granted

  6. US 10280422

    MiR-92 inhibitors and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted May 7, 2019 · Expires May 2, 2039

    granted

  7. US 10272074

    Inhibitors of glucocorticoid receptor translocation

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  8. US 10272084

    Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  9. US 10273233

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  10. US 10273218

    BCL-3 inhibitors

    University College Cardiff Consultants Limited · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  11. US 10272132

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  12. US 10266488

    4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  13. US 10266542

    EZH2 inhibitors

    Mirati Therapeutics, Inc. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  14. US 10266539

    Polymorph of Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  15. US 10265313

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  16. US 10266549

    ULK1 inhibitors and methods using same

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  17. US 10258627

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  18. US 10253044

    9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  19. US 10251874

    Crystalline forms of a JAK inhibitor compound

    Theravance Biopharma R&D IP, LLC · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  20. US 10253039

    Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria

    The Regents of the University of California · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  21. US 10246463

    Hypoxia-inducible factor 1 (HIF-1) inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  22. US 10239832

    N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  23. US 10239837

    Piperidine derivatives as HDAC1/2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  24. AU 2017305856

    Pharmaceutical formulations of C1 esterase inhibitor

    CSL BEHRING GMBH [DE] · Granted Mar 21, 2019 · Expires Mar 16, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.